AA-amyloidosis prevalence in rheumatic diseases (according to data of SI Institute of Rheumatology RAMS) by Y. V. Muravyov, A. V. Alexeeva

Get full text

Indications and use of diclofenac sodium injection form in rheumatic diseases by Y. V. Muravjov, A. V. Alexeeva, E. V. Osipova

Get full text

Unusual course of AA amiloidosis in a patient with rheumatoid arthritis by Y V Muravjev, S G Radenska-Lopovok, A V Alexeeva, E G Lyubimova, T M Novoselova

Get full text

Rationales for discontinuation of disease-modifying antirheumatic drugs, biologic agents, and tofacitinib in rheumatoid arthritis by Yu. V. Muraviev, G. I. Gridneva, L. A. Muravieva, N. V. Muravieva, A. V. Alexeeva, K. S. Nurbaeva, K. M. Mikhailov, A. V. Rozov

Get full text